Today: 5 March 2026
Browse Category

Earnings Reports 4 November 2025 - 5 November 2025

Teva Stock Soars on Earnings Beat: Inside Teva’s 2025 Comeback and What’s Next for Investors

Teva Stock Soars on Earnings Beat: Inside Teva’s 2025 Comeback and What’s Next for Investors

Teva Pharmaceutical reported Q3 2025 adjusted EPS of $0.78 on $4.48 billion revenue, beating estimates and sending shares up 10–11% to a new 52-week high. The company raised 2025 guidance, citing strong sales of Austedo and other branded drugs, and Fitch upgraded its credit rating in May. Debt fell to $16.79 billion. Teva’s forward P/E remains below industry averages despite the stock’s sharp recovery.
Axon Enterprise (AXON) Stock Plunges on Earnings Miss – What’s Next for the Taser Maker?

Axon Enterprise (AXON) Stock Plunges on Earnings Miss – What’s Next for the Taser Maker?

Axon Enterprise shares plunged nearly 20% in early November 2025 after missing third-quarter profit estimates, dropping from $706 to the mid-$560s. The company raised its full-year revenue forecast to $2.74 billion, citing 31% growth and strong demand for new products. Axon announced a $625 million acquisition of Carbyne to expand its public safety tech portfolio. The stock’s post-earnings drop erased its year-to-date gains.
Humana (HUM) Stock on Nov 5, 2025: Earnings Beat, Outlook Trimmed – Full Analysis

Humana (HUM) Stock on Nov 5, 2025: Earnings Beat, Outlook Trimmed – Full Analysis

Humana shares traded at $269 on Nov 5, 2025, after Q3 earnings beat expectations with adjusted EPS of $3.24 and revenue of $32.65 billion. The company reaffirmed full-year adjusted EPS guidance but cut its GAAP forecast due to higher medical costs. Shares fell 4% pre-market. Humana projects a 7% drop in Medicare Advantage membership for 2025 after a major plan’s star rating downgrade.
Zeta Global (ZETA) – 17th Straight Beat & Raise Quarter Ignites AI-Cloud Rally – Analysts Eye ~$28 Target (≈+70% Upside)

Zeta Global (ZETA) – 17th Straight Beat & Raise Quarter Ignites AI-Cloud Rally – Analysts Eye ~$28 Target (≈+70% Upside)

Zeta (NYSE: ZETA) closed Nov. 4, 2025 at $16.70, down 5.2%, with after-hours trading near $18.06. Q3 revenue rose 26% year-over-year to $337.4 million, with net cash from operations up 68%. The company raised its FY2025 revenue outlook to $1.273–1.276 billion. Analyst consensus rates ZETA a “Strong Buy,” with an average 12-month price target of $28.
Rivian Slashes 600 Jobs as EV Demand Slumps – Stock Hits & Experts Sound Alarm

Rivian Rally or Risk? EV Start-up Stock Jumps on Q3 Beat, Layoffs & R2 Hype

Rivian reported Q3 2025 revenue of $1.56 billion, up 78% year-over-year, and delivered 13,201 vehicles, its highest quarterly total. The company turned a positive adjusted gross profit of $24 million and reaffirmed 2025 delivery guidance at 41,500–43,500 vehicles. Shares closed at $12.98 on Nov. 4, down 5.2%, with a market cap near $15.2 billion. Rivian announced 600 layoffs in October to cut costs.
Axon Stock Rockets 420% Overseas as Wall Street Targets $1,000 – Should You Buy the Dip?

Axon Enterprise Rockets Past Revenue Goals – But EPS Miss Sends Stock Reeling

Axon reported Q3 2025 revenue of $711 million, up 31% year-over-year, led by 41% growth in Software & Services sales. The company posted a GAAP net loss of $2 million but non-GAAP net income of $98 million. Shares dropped about 14% after earnings, trading near $608, though the market cap remains around $56.9 billion. Management raised full-year revenue guidance to approximately $2.74 billion.
Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer Stock’s Wild November Ride: Earnings Beat, Obesity Drug Battle & Bold Forecasts

Pfizer shares traded near $24.60 on Nov. 4, 2025, down about 8–9% year-to-date and over 60% from their 2021 peak. Q3 adjusted earnings beat forecasts at $0.87 per share, but revenue missed slightly at $16.65 billion. Pfizer raised its full-year profit outlook and reaffirmed revenue guidance. The company is locked in a takeover battle with Novo Nordisk for obesity drug developer Metsera.
Axcelis (ACLS) Stock Jumps on Q3 Earnings Beat and Veeco Merger: Key Insights & Outlook

Axcelis (ACLS) Stock Jumps on Q3 Earnings Beat and Veeco Merger: Key Insights & Outlook

Axcelis shares closed at $86.24 on Nov. 4, up 5% after Q3 earnings beat estimates with $213.6 million revenue and $1.21 non-GAAP EPS. The stock is down about 20% over the past year but up 235% over five years. Axcelis announced an all-stock merger with Veeco Instruments in October, valuing the combined company at $4.4 billion. Wall Street rates the stock between Hold and Buy, with an average target of $97.
SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. shares fell 12% to $1.93 on Nov. 4 after reporting a Q3 net loss of C$11.1 million despite record free cash flow and 3.1% revenue growth to C$244.2 million. The stock is up about 10% year-to-date but down nearly 15% in the past month. SNDL holds C$240.6 million in cash and no debt. Analyst consensus remains “Hold” with a $2.50 price target.
Surprise Earnings Miss Sends Marathon Petroleum (MPC) Stock Tumbling – What’s Next for This Oil Giant?

Surprise Earnings Miss Sends Marathon Petroleum (MPC) Stock Tumbling – What’s Next for This Oil Giant?

Marathon Petroleum reported Q3 2025 net income of $1.4 billion, more than double a year ago, but adjusted EPS of $3.01 missed estimates. Shares fell 7–8% after the report, trading near $180, down from recent highs around $200. Revenue topped forecasts at $35.85 billion, but higher maintenance costs weighed on results. The company raised its quarterly dividend 10% to $1.00 per share.
Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple Stock Soars to Record High After Huge Q4 Earnings Beat – What’s Next for AAPL in 2025?

Apple traded near $269 on Nov. 4, 2025, close to its 52-week high of $277.32, with shares up 26% since August and market cap at $3.95 trillion. The company reported record Q4 revenue of $102.5 billion, up 8% year-over-year, and forecast double-digit iPhone sales growth for the holiday quarter. Analyst targets are split, with consensus near $285. Technical resistance is seen at $275–$280.
Alphabet Stock Skyrockets on $100B Quarter: Google’s AI Bet, Big Earnings & What’s Next

Alphabet Stock Skyrockets on $100B Quarter: Google’s AI Bet, Big Earnings & What’s Next

Alphabet shares traded near $280 on Nov. 4, 2025, close to record highs after Q3 earnings beat forecasts, with revenue up 16% to $102.3 billion and net income at $35 billion. Google’s ad revenue rose 13% to $74.2 billion, while Google Cloud jumped 34% amid surging AI demand. A U.S. antitrust ruling let Alphabet keep control of Android and Chrome. The company raised 2025 capex to up to $93 billion for AI and data centers.
Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts

Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts

Tesla shares traded near record highs at $468 on Nov. 4, 2025, after a 2.6% jump, despite a Q3 earnings miss. The Nov. 6 shareholder meeting will vote on Elon Musk’s proposed $1 trillion pay package, which Norway’s sovereign fund opposes. Tesla began producing a sub-$40,000 Model Y in Germany and rolled out FSD v14 to Cybertrucks. Q3 revenue rose 12% to $28.1 billion, but net income fell 37% to $1.37 billion.
Upwork Stock Soars on AI-Fueled Earnings Beat – Key Facts & Expert Outlook

Upwork Stock Soars on AI-Fueled Earnings Beat – Key Facts & Expert Outlook

Upwork reported Q3 2025 revenue of $201.7 million, beating estimates, and raised its full-year outlook above consensus. Shares surged nearly 20% to around $17 after the results. Wall Street analysts boosted price targets, with Goldman Sachs setting a $25 target citing AI-driven growth. AI-related freelance work on the platform jumped 53% year-over-year.
SoFi Stock Soars to All-Time High on Record Earnings – What’s Next for SOFI Investors?

SoFi Stock Soars to All-Time High on Record Earnings – What’s Next for SOFI Investors?

SoFi Technologies shares have surged 96% year-to-date and closed at $30.63 on Nov. 3, 2025, after hitting a record $32.57 in late October. Q3 revenue jumped 38% to $950 million, with net income at $139 million and a raised 2025 EPS forecast to $0.37. The company added 905,000 new members in Q3, reaching 12.6 million users, and loan originations hit $9.9 billion.
Apollo Global Management Stock Soars on Earnings Beat – Big Deals and 2025 Outlook

Apollo Global Management Stock Soars on Earnings Beat – Big Deals and 2025 Outlook

Apollo Global Management shares jumped nearly 7% to $132.50 on Nov. 4, 2025, after Q3 earnings beat expectations, but remain about 25% below their 2025 starting level. Adjusted net income rose 20% to $1.36 billion. Assets under management reached $908 billion, boosted by $82 billion in quarterly inflows. Apollo agreed to invest $6.5 billion in Ørsted’s Hornsea 3 wind farm and co-led a $7 billion deal for Keurig Dr Pepper.
1 212 213 214 215 216 226
Go toTop